Approval · Notice of Compliance 3969 · 1997
NAPROXEN: Notice of Compliance 3969
Issued August 1, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3969
- Date
- August 1, 1997
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anti-inflammatory agent, analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAPROXEN | 02230477 | Cancelled Post Market |
Medicinal ingredients
- NAPROXEN 500 MG per SUP